ライフサイエンスコーパス: intra-abdominal fat

1 bcutaneous fat area (r = 0.760) but not with intra-abdominal fat.

2 of overweight, nor the detrimental effect of intra-abdominal fat.

3 ered free fatty acid kinetics, and increased intra-abdominal fat.

4 al secretion of insulin, and 3) increases in intra-abdominal fat.

5 n(-1)/[pmol/l]), P < 0.01) was decreased and intra-abdominal fat (117 +/- 10 vs. 81 +/- 9 cm(2), P <

6 al body fat (-1.0%; 95% CI, -1.6% to -0.4%), intra-abdominal fat (-8.6 g/cm2; 95% CI, -17.8 to 0.9 g/

7 y derived from lipolysis of intrahepatic and intra-abdominal fat and de novo lipogenesis.

8 hey had similar leptin levels, whereas their intra-abdominal fat and insulin sensitivity remained dif

9 alpha-MSH decreased intra-abdominal fat and markedly enhanced the actions of

10 of conventional anthropometric indices with intra-abdominal fat and subcutaneous fat areas measured

11 8 years of predominately white ethnicity had intra-abdominal fat and subcutaneous fat areas measured

12 Intra-abdominal fat and subcutaneous fat areas were quan

13 odds ratios of hypertension for quartiles of intra-abdominal fat area (1 = lowest; 4 = highest) were

14 Intra-abdominal fat area (IAFA) was associated with a hi

15 Both baseline intra-abdominal fat area (P = 0.002) and HOMA-IR (P < 0.

16 Visceral adiposity was measured as intra-abdominal fat area at the umbilicus level.

17 Direct measurement of intra-abdominal fat area by magnetic resonance imaging,

18 d lower percentages of the total variance in intra-abdominal fat area for men than for women.

19 Waist : hip ratio was linearly related to intra-abdominal fat area in both sexes.

20 r body mass index is used as a surrogate for intra-abdominal fat area in men, a quadratic term should

21 Intra-abdominal fat area remained a significant predicto

22 The intra-abdominal fat area remained a significant risk fac

23 On average, women had a lower intra-abdominal fat area than men (109.5 cm2 vs. 152.9 c

24 The intra-abdominal fat area was associated with an increase

25 After adjustment for age, intra-abdominal fat area was quadratically associated wi

26 as the sum of these fat areas excluding the intra-abdominal fat area.

27 or hypertension in models that contained the intra-abdominal fat area.

28 he variance in subcutaneous fat area than in intra-abdominal fat area.

29 fat area was defined as total fat area minus intra-abdominal fat area.

30 A-IR at 10-11 years in models that contained intra-abdominal fat area.

31 The subcutaneous and intra-abdominal fat areas, determined by computed tomogr

32 Intra-abdominal fat, assessed by computed tomography, is

33 Women appear to deposit intra-abdominal fat at a constant rate as they gain weig

34 atheterization techniques to examine whether intra-abdominal fat contributes a greater portion of hep

35 Thus, accumulation of intra-abdominal fat correlates with insulin resistance,

36 ese results indicate that among men, greater intra-abdominal fat deposition rates occur at relatively

37 Other measures included subcutaneous and intra-abdominal fat from computed tomography scans, weig

38 on of the insulin sensitivity index (Si) and intra-abdominal fat (IAF) and subcutaneous fat (SCF) are

39 Intra-abdominal fat (IAF) area (square centimeters) was

40 Increasing intra-abdominal fat (IAF) area, quantified by computed t

41 These data suggest that although intra-abdominal fat is a strong determinant of insulin s

42 s to decreased ovarian reserve and increased intra-abdominal fat mass in granddaughters, accompanied

43 duced interscapular brown adipose tissue and intra-abdominal fat mass, and increased extra-abdominal

44 function with age is related to increases in intra-abdominal fat or age per se, we studied 220 health

45 ditional port placement because of excessive intra-abdominal fat or limited abdominal domain.

46 t not age was associated with S(i), but both intra-abdominal fat (r = -0.198, P = 0.003) and age (r =

47 In multiple regression, intra-abdominal fat (r = -0.470, P < 0.001) but not age

48 d patients on indinavir treatment accumulate intra-abdominal fat that may cause abdominal symptoms.

49 Increased intra-abdominal fat (visceral adiposity) with CHD is ind

50 Intra-abdominal fat was the best variable predicting ins

51 Changes in weight and intra-abdominal fat were not significantly different bet